5NBI image
Deposition Date 2017-03-02
Release Date 2017-09-27
Last Version Date 2024-10-16
Entry Detail
PDB ID:
5NBI
Keywords:
Title:
Principles for computational design of antibodies
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.10 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Design of antibodies
Chain IDs:A (auth: H)
Chain Length:233
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polypeptide(L)
Molecule:Design of antibodies
Chain IDs:B (auth: L)
Chain Length:218
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Principles for computational design of binding antibodies.
Proc. Natl. Acad. Sci. U.S.A. 114 10900 10905 (2017)
PMID: 28973872 DOI: 10.1073/pnas.1707171114

Abstact

Natural proteins must both fold into a stable conformation and exert their molecular function. To date, computational design has successfully produced stable and atomically accurate proteins by using so-called "ideal" folds rich in regular secondary structures and almost devoid of loops and destabilizing elements, such as cavities. Molecular function, such as binding and catalysis, however, often demands nonideal features, including large and irregular loops and buried polar interaction networks, which have remained challenging for fold design. Through five design/experiment cycles, we learned principles for designing stable and functional antibody variable fragments (Fvs). Specifically, we (i) used sequence-design constraints derived from antibody multiple-sequence alignments, and (ii) during backbone design, maintained stabilizing interactions observed in natural antibodies between the framework and loops of complementarity-determining regions (CDRs) 1 and 2. Designed Fvs bound their ligands with midnanomolar affinities and were as stable as natural antibodies, despite having >30 mutations from mammalian antibody germlines. Furthermore, crystallographic analysis demonstrated atomic accuracy throughout the framework and in four of six CDRs in one design and atomic accuracy in the entire Fv in another. The principles we learned are general, and can be implemented to design other nonideal folds, generating stable, specific, and precise antibodies and enzymes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures